Indigo Biosciences

Provider of nuclear receptor and in vitro toxicology solutions

placeState College, Pennsylvania, United States calendar_todayFounded 2005 groups17 employees language indigobiosciences.com

Registered entities

Social engagement

Social engagement: 2.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include LSGPA, Allied Growth Strategies & Management.

Investor typeCountShare
Venture capital250%
Private equity250%

Recent activity

2 Jul 2026
Product launch
Human Bradykinin B1R and B2R receptor assays
30 Jun 2026
Product launch
Stable Reporter Cell Lines
16 Jun 2026
Product launch
INDIGO's GPCR stable reporter cell line engineering platform
Coming soon